Relationship Between FGF19 Overexpression and Disease Prognosis
NCT06938451 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-04-22
Summary
A real-world study of FGF19 overexpression status and treatment outcome and prognosis in advanced hepatocellular carcinoma
Conditions
- Hepatocellular Carcinoma (HCC)
Interventions
- OTHER
-
This is an observational study and does not involve an intervention
Sponsors & Collaborators
-
Beijing Tsinghua Chang Gung Hospital
lead OTHER
Principal Investigators
-
ZHAOYING Resident physician, phD · Beijing Tsinghua Changgeng Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-01
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- China
Study Locations
More Related Trials
-
Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC Patients
NCT06577272 ·Status: RECRUITING
-
Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension
NCT06245798 ·Status: COMPLETED
-
Calculator Predicts Early Mortality Post Hepatocellular Carcinoma Resection
NCT06621485 ·Status: COMPLETED
-
The Surveillance of Hepatocellular Carcinoma
NCT05286099 ·Status: UNKNOWN
-
A Study of Laparoscopic Hepatectomy Versus RFA in the Treatment of Recurrent HCC
NCT03313648 ·Status: UNKNOWN ·Phase: NA
-
Downstaging Prediction Model for HCC
NCT07058649 ·Status: NOT_YET_RECRUITING
-
Management of Spontaneous Ruptured Hepatocellular Carcinoma
NCT03516890 ·Status: COMPLETED
-
CT Perfusion Parameters Predict Vascular Pattern in Hepatocellular Carcinoma
NCT04715321 ·Status: UNKNOWN
-
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
NCT06537193 ·Status: RECRUITING ·Phase: NA
-
A New Prognostic Scoring System for Spontaneous Ruptured Hepatocellular
NCT03504358 ·Status: COMPLETED
-
Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion
NCT07170345 ·Status: RECRUITING
-
Transient Elastography in Hepatectomy for Hepatocellular Carcinoma
NCT01441453 ·Status: UNKNOWN ·Phase: NA
-
Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease
NCT03635541 ·Status: UNKNOWN
-
The Utility of Cell-free Methylation Markers in Blood for Hepatocellular Carcinoma
NCT05576571 ·Status: UNKNOWN
-
Tumor Growth Factors in Hepatocellular Carcinoma
NCT00764140 ·Status: COMPLETED
-
Prospective Surveillance for Very Early Hepatocellular Carcinoma
NCT03588442 ·Status: UNKNOWN
-
Hepatocellular Carcinoma Growth and Molecular Aggressiveness
NCT01657695 ·Status: COMPLETED
-
Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCC
NCT02535117 ·Status: UNKNOWN ·Phase: PHASE4
-
Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC)
NCT02898415 ·Status: COMPLETED
-
Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma
NCT02526043 ·Status: UNKNOWN ·Phase: NA
-
Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy
NCT01281683 ·Status: UNKNOWN
-
Pretreatment MRI Predicting Outcome After Radio-frequency Ablation of HCC
NCT02051283 ·Status: UNKNOWN
-
A Head-to-head Comparison of MRI, CT, 18F-FDGal and 18F-choline in Patients With Hepatocellular Carcinoma
NCT05359939 ·Status: RECRUITING ·Phase: NA
-
Prognostic Impact of Anatomical Resection Vs. Non-anatomical Resection for HCC
NCT01236989 ·Status: UNKNOWN ·Phase: NA
-
Non-contrast Abbreviated MRI for Secondary Surveillance of HCC
NCT05690451 ·Status: COMPLETED